Telerehabilitation Versus Supervised Pelvic Floor Muscle Training in Urinary Incontinence (NCT07151170) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Telerehabilitation Versus Supervised Pelvic Floor Muscle Training in Urinary Incontinence
Pakistan54 participantsStarted 2026-02-01
Plain-language summary
Urinary Incontinence (UI) is a prevalent condition impacting women across all age groups, varing in both severity and type. Urinary Incontinence affects 25%-45% of women worldwide. A systematic review explains that menopause-driven estrogen decline leads to atrophy of pelvic floor muscles (PFM). The goal of this randomized controlled trial is to compare the effects of telerehabilitation-based pelvic floor muscle training with a supervised face-to-face pelvic floor muscle training program in improving urinary incontinence symptoms, pelvic floor muscle funtion and quality of life (QoL) in postmenopausal women. Participnts will be randomly assigned to one of the two groups, and both will receive an identical standardized pelvic floor muscle training protocol. The results of this clinical trial will help evaluate how telerehabilitation can provide support for postmenopausal women with urinary incontinence and improve health outcomes.
Who can participate
Age range
45 Years – 65 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Postmenopausal women between the ages of 45-65.
* Postmenopausal status, defined as absence of menstruation for more than 12 months.
* Experiencing symptomatic urinary incontinence, indicated by a Questionnaire for Urinary Incontinence Diagnosis (QUID) score greater than "0".
* Able to comprehend and accurately respond to the questionnaire (i.e., no language barriers) and reading and writing Urdu language.
* Free from any physical or psychological conditions that could hinder participation in the study.
* Participants must have access to both the internet and a mobile phone/laptop
* Signing the informed consent form.
Exclusion Criteria:
* Women with cognitive impairments, neurological disorders, pelvic malignancies.
* Individuals with a history of intra-abdominal and pelvic surgery or radiation therapy.
* Presence of active urinary tract/vaginal infection
* Presence of incontinence except stress and urge urinary incontinence (e.g. overflow incontinence or dribbling urine after urination)
* Presence of voiding dysfunction (e.g. incomplete voiding, intermittent urination or delay in starting to urinate)
* Women with contraindications to pelvic floor muscle training (e.g., pelvic pain resulting from endometriosis, coccydynia or anismus, unexplained vaginal bleeding and anal fissure).
* Women aged over 65 years
* Body mass index ≥ 27.4 kg/m²
* Currently undergoing hormone therapy
* Lack of pelvic floor muscle contraction ability (pelvic floor muscle stren…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) score
Timeframe: Baseline and 6 weeks
2
Change in pelvic floor muscle strength using the Modified Oxford Scale
Timeframe: Baseline and 6 weeks
3
Change in Urinary Impact Questionnaire short form (UIQ-7) score
Timeframe: Baseline and 6 weeks
4
Change in Incontinence Impact Questionnaire, Short Form (IIQ-7) score